Last edition
News about "Metsera"
Pfizer Completes Acquisition of Metsera
Pfizer has finalised its acquisition of Metsera, adding a portfolio of differentiated, clinical-stage obesity therapies with the potential to redefine future treatment standards. The deal strengthens and reshapes Pfizer’s internal medicine portfolio, positioning the company to compete more aggressively in therapeutic areas, globally.
Metsera | 14/11/2025 | By Dineshwori
Novo Nordisk Confirms No Further Proposal Increase for Metsera Acquisition
Novo Nordisk has confirmed that it will not increase its offer to acquire Metsera, ending speculation of a potential bidding escalation.
Metsera | 10/11/2025 | By Dineshwori | 102
Novo Nordisk Submits Updated Proposal to Acquire Metsera in Multi-Billion-Dollar Deal
Novo Nordisk has confirmed that it has submitted an updated, unsolicited proposal to acquire Metsera, which has been declared superior by Metsera’s board of directors.
Metsera | 06/11/2025 | By Dineshwori | 110
Novo Nordisk Makes Unsolicited USD 6.5 Billion Bid to Acquire Metsera
Novo Nordisk, a leading global healthcare company founded in 1923 and headquartered in Denmark, has announced that it has submitted an unsolicited proposal to acquire Metsera, Inc.
Metsera | 01/11/2025 | By Darshana | 134
Pfizer to Acquire Metsera, Expand Obesity and Cardiometabolic Drug Pipeline
Pfizer is set to acquire Metsera, a clinical-stage biopharmaceutical company focused on developing the next generation of medicines for obesity and cardiometabolic diseases.
Metsera | 23/09/2025 | By Dineshwori | 102
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy